ArticleKidney international reports2025

Efficacy and Safety of Telitacicept as an Add-On Therapy for Refractory Immunoglobulin A Nephropathy or Immunoglobulin A Vasculitis Nephropathy in Children.

Jiaojiao Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.